BAVIS_1170x120_1-20

hydrocodone bitartrate and homatropine methylbromide oral solution

Perrigo cleared to market cough syrup

Perrigo cleared to market cough syrup

DUBLIN, Ireland — Perrigo Co. plc has received approval from the Food and Drug Administration for hydrocodone bitartrate and homatropine methylbromide oral solution 5 mg/1.5 mg per 5 ml. Hydrocodone bitartrate and homatropine methylbromide syrup is indicated for the symptomatic relief of cough in adults and children ages 6 and older. A combination medication, the